Sharekhan

Dr Agarwals Health Care Ltd

Fri 9/01/2026,15:59:58 NSE: AGARWALEYE

₹ 504.50 1.10 (0.22%)
BUY NOW Buy Dr Agarwals Health Care Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Dr Agarwals Health Care Ltd

Fri 9/01/2026,16:1:0

Dr Agarwals Health Care Ltd

Fri 9/01/2026,15:59:58 | NSE : AGARWALEYE

₹ 504.501.10 (0.22%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 500.50

Previous Close

₹ 503.40

Volume

146829

Mkt Cap ( Rs. Cr)

₹15982.94

High

₹ 511.00

Low

₹ 496.50

52 Week High

₹ 568.00

52 Week Low

₹ 327.00

Book Value Per Share

₹ 60.95

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Dr Agarwals Health Care Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

504.50

638

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

638

Option Chain

Analyzes market sentiment, predicts Dr Agarwals Health Care Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dr. Agarwals Health - ESOP/ESOS/ESPS

    6 Jan 2026, 11:40AM Dr. Agarwal's Health Care Limited has informed the Exchange regarding Allotment of 337504 Equity Shares of INR 1 each upon exercise of 337504 options.

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    6 Jan 2026, 11:43AM As per the letter enclosed.

  • Dr. Agarwals Health - Trading Window

    26 Dec 2025, 7:12PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Reg

  • Dr. Agarwals Health - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    19 Dec 2025, 1:49PM The voting results in the prescribed format along with the Scrutinizer's Report on remote e-voting, for the Postal Ballot Notice dated November 12, 20

  • Dr. Agarwals Health - Shareholders meeting

    19 Dec 2025, 1:47PM The Voting Results in the prescribed format along with the Scrutinizer's Report on remote e-voting, for the Postal Ballot Notice dated November 12, 20

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    12 Dec 2025, 9:52PM As per the letter enclosed.

  • Dr. Agarwals Health - Allotment of Securities

    12 Dec 2025, 9:45PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding allotment of 299122 Equity shares of INR 1 each pursuant to ESOP/ESPS through ci

  • Dr. Agarwals Health - Copy of Newspaper Publication

    18 Nov 2025, 4:54PM Newspaper advertisement for Notice of Postal Ballot and e-voting information

  • Dr. Agarwals Health - Shareholders meeting

    17 Nov 2025, 2:46PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding Notice of Postal Ballot

  • Dr. Agarwals Health - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    17 Nov 2025, 2:48PM Postal Ballot Notice dated November 12, 2025, along with explanatory statement, is enclosed.

  • Dr. Agarwals Health - Resignation of Statutory Auditor

    12 Nov 2025, 6:12PM DR. AGARWAL'S HEALTH CARE LIMITED has informed the Exchange about Resignation of Statutory Auditor

  • Dr. Agarwals Health - Change in Auditors

    12 Nov 2025, 5:17PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding Change in Auditors of the company.

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    12 Nov 2025, 5:19PM Change in Statutory Auditors of the Company and its Material Indian Subsidiary.

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Nov 2025, 3:16PM As per the letter enclosed.

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Nov 2025, 3:11PM Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    4 Nov 2025, 6:04PM As per the letter enclosed.

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Nov 2025, 5:59PM Dr. Agarwal's Health Care Limited has informed the Exchange about Transcript

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    31 Oct 2025, 1:46PM As per letter enclosed

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Oct 2025, 1:42PM Dr. Agarwal's Health Care Limited has informed the Exchange about Link of Recording

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Investor Presentation

    31 Oct 2025, 11:12AM As per the letter enclosed.

  • Dr. Agarwals Health - Investor Presentation

    31 Oct 2025, 11:08AM Dr. Agarwal's Health Care Limited has informed the Exchange about Investor Presentation

  • Dr. Agarwals Health posts Q2 net profit of Rs 4.68 cr

    30 Oct 2025, 8:41PM The company reported standalone net profit during the quarter stood at Rs 4.68 crore compared to net loss of Rs 3.68 crore in the previous year quarte

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    30 Oct 2025, 8:30PM As per the letter enclosed.

  • Dr. Agarwals Health - Monitoring Agency Report

    30 Oct 2025, 8:27PM Monitoring Agency Report for the quarter ended September 30, 2025

  • Dr. Agarwals Health - General Updates

    30 Oct 2025, 8:11PM Dr. Agarwal's Health Care Limited has informed the Exchange regarding the allotment of shares and grant of options under Dr. Agarwal's Health Care Lim

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    30 Oct 2025, 7:59PM As per the letter enclosed.

  • Dr. Agarwals Health - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 3

    30 Oct 2025, 7:32PM As per the letter enclosed.

  • Dr. Agarwals Health - Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone & Consolidated) For T

    30 Oct 2025, 7:27PM As per the letter enclosed

  • Dr. Agarwals Health - Outcome of Board Meeting

    30 Oct 2025, 7:24PM Dr. Agarwal's Health Care Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

  • Dr. Agarwals Health - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Oct 2025, 12:54PM Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    28 Oct 2025, 12:57PM As per letter enclosed

  • Dr. Agarwals Health - Board Meeting Intimation for Considering And Approving Unaudited Financial Results (Standalone And Cons

    22 Oct 2025, 4:39PM Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 ,inter alia, to cons

  • Dr. Agarwals Health - Credit Rating

    14 Oct 2025, 5:13PM Dr. Agarwal's Health Care Limited has informed the Exchange about Credit Rating

  • Dr. Agarwals Health has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    14 Oct 2025, 5:40PM As of September 2025, 32.43% is owned by Indian Promoters and 67.58% by Public. <p align=justify> Institutional holds 66.05% (Foreign Portfolio Invest

  • Dr. Agarwals Health - Announcement under Regulation 30 (LODR)-Credit Rating

    14 Oct 2025, 5:11PM As per letter enclosed
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Dr Agarwals Health Care Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2078.86 1559.19 868.81 450.768
Liabilities 2078.86 1559.19 868.81 450.768
Equity 31.59 9.33 7.93 6.86
Gross Profit 245.1 221.1 159.28 84.5478
Net Profit 21.93 23.83 31.59 -1.4741
Cash From Operating Activities 208 221.58 152.69 78.2919
NPM(%) 2.1 2.85 5.28 -0.4
Revenue 1043.89 835.06 597.64 361.5898
Expenses 798.79 613.96 438.36 277.042
ROE(%) 1.13 1.23 1.63 -0.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dr Agarwals Health Care Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 731.10 -2.46 0.00 288.44 301.39 0.68
Lotus Eye Hospital and Institute Ltd 111.58 -3.38 348.69 1051.04 3.55 0.00
Vaishali Pharma Ltd 8.57 1.06 0.00 6593.55 3.13 0.00
Astec Lifesciences Ltd 639.40 -3.82 0.00 991.16 -604.77 0.00

Company Info

Our Company was incorporated as `Dr. Agarwal's Health Care Limited' at Chennai, Tamil Nadu as a public limited company under the Companies Act, 1956, pursuant to the certificate of incorporation dated April 19, 2010, issued by the RoC and commenced operations pursuant to the certificate for commencement of business dated May 29, 2010, issued by the RoC.Major Events and Milestones:2010- Incorporation of our Company.- Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.2011- Investment by EILSF SPV 3 in our Company.2012- Entry into the Africa market by entering into an agreement with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.2017- Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.2019- Investment by Claymore Investments (Mauritius) Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.- Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.2021- Our Company launched its 100th eye care facility.2022- Investment by TPG Capital's Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.- Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.- Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP, Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani2023- Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh2024- Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.- Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.

Our Company was incorporated as `Dr. Agarwal's Health Care Limited' at Chennai, Tamil Nadu as a public limited company under the Companies Act, 1956, pursuant to the certificate of incorporation dated April 19, 2010, issued by the RoC and commenced operations pursuant to the certificate for commencement of business dated May 29, 2010, issued by the RoC.Major Events and Milestones:2010- Incorporation of our Company.- Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.2011- Investment by EILSF SPV 3 in our Company.2012- Entry into the Africa market by entering into an agreement with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.2017- Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.2019- Investment by Claymore Investments (Mauritius) Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.- Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.2021- Our Company launched its 100th eye care facility.2022- Investment by TPG Capital's Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.- Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.- Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP, Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani2023- Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh2024- Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.- Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.

Read More

Parent Organisation

Dr. Agarwals Health Care Ltd.

Founded

19/04/2010

Managing Director

Dr.Adil Agarwal

NSE Symbol

AGARWALEYEEQ

FAQ

The current price of Dr Agarwals Health Care Ltd is ₹ 504.50.

The 52-week high for Dr Agarwals Health Care Ltd is ₹ 511.00 and the 52-week low is ₹ 496.50.

The market capitalization of Dr Agarwals Health Care Ltd is currently ₹ 15982.94. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dr Agarwals Health Care Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dr Agarwals Health Care Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dr Agarwals Health Care Ltd shares.

The CEO of Dr Agarwals Health Care Ltd is Dr.Adil Agarwal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT